BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 11252906)

  • 1. [AL amyloidosis].
    Hedeshi AR; Brenez D; Benaddia L; Vandervelde D; Khodadadi E; Ardichvili D; Malarme M
    Rev Med Brux; 2001 Feb; 22(1):9-14. PubMed ID: 11252906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic heart failure in patients with cardiac amyloidosis].
    Solomakhina NI; Varshavskiĭ VA; Gundarova LV; Golitsina EP; Shchekochikhin DIu
    Klin Med (Mosk); 2009; 87(3):26-30. PubMed ID: 19469251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic light-chain amyloidosis presenting with rapid progressive heart failure.
    Sunbul M; Durmus E; Kivrak T; Besiroglu F; Gerin F; Sari I; Mutlu B
    Ther Adv Cardiovasc Dis; 2013 Aug; 7(4):224-7. PubMed ID: 23868674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary amyloidosis associated to severe factor X deficiency].
    Pérez Martínez J; Llamas F; López Montes A; Massó P; Poblet E; López Rubio E; Gallego E; Gómez Roldán C
    Nefrologia; 2004; 24(5):493-8. PubMed ID: 15648909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary (AL) amyloidosis in plasma cell disorders.
    Müller AM; Geibel A; Neumann HP; Kühnemund A; Schmitt-Gräff A; Böhm J; Engelhardt M
    Oncologist; 2006; 11(7):824-30. PubMed ID: 16880241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Systemic amyloidosis revealed by an intense nephrotic syndrome].
    Sanmartin N; Janvier F; Chianea D; Fagot T; Renard C; Vest P
    Ann Biol Clin (Paris); 2011; 69(1):121-5. PubMed ID: 21464002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrotic syndrome secondary to amyloidosis.
    Kneipp S; Himmelstein SB
    Nurse Pract; 2000 Jun; 25(6 Pt 1):78, 81, 85-6 passim. PubMed ID: 10884998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light-chain (AL) amyloidosis: diagnosis and treatment.
    Sanchorawala V
    Clin J Am Soc Nephrol; 2006 Nov; 1(6):1331-41. PubMed ID: 17699366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
    Picken MM
    Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances in diagnosis and treatment of AL amyloidosis].
    Zelichowski G; Lubas A; Wańkowicz Z
    Pol Merkur Lekarski; 2008 Apr; 24(142):340-5. PubMed ID: 18634370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis.
    Sanchorawala V; Wright DG; Seldin DC; Dember LM; Finn K; Falk RH; Berk J; Quillen K; Skinner M
    Bone Marrow Transplant; 2001 Oct; 28(7):637-42. PubMed ID: 11704785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe heart failure from light chain cardiomyopathy (cardiac amyloidosis).
    Hofer JF; Wimmer G
    Z Kardiol; 2003 Jan; 92(1):90-5. PubMed ID: 12545307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AL amyloidosis with renal involvement.
    Rysavá R
    Kidney Blood Press Res; 2007; 30(6):359-64. PubMed ID: 17851224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heart failure in amyloidosis--a rare but treatable disease].
    Ohlsson M; Oldfors A; Hallgren P
    Lakartidningen; 2002 May; 99(21):2386-8, 2391. PubMed ID: 12090165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis.
    Bergesio F; Ciciani AM; Santostefano M; Brugnano R; Manganaro M; Palladini G; Di Palma AM; Gallo M; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2007 Jun; 22(6):1608-18. PubMed ID: 17395661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of rapidly progressive liver light chain deposition under VAD chemotherapy in multiple myeloma.
    Samanez C; Domingo A; Cibeira MT; Miquel R; Soler M; Bladé J
    Eur J Haematol; 2006 Jan; 76(1):83-5. PubMed ID: 16343276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behind heart failure syndrome: remember AL amyloidosis. Two case-reports.
    Silva D; Sargento L; Varela MG; Brito D; Lopes MG
    Rev Port Cardiol; 2010 Nov; 29(11):1751-9. PubMed ID: 21309362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective and well tolerated treatment with melphalan and dexamethasone for primary systemic AL amyloidosis with cardiac involvement.
    YOSHIZAWA S; AKAHANE D; FUJIMOTO H; GOTOH M; KIGUCHI T; TAUCHI T; OHYASHIKI K
    Rinsho Ketsueki; 2009 Nov; 50(11):1647-51. PubMed ID: 20009442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary systemic amyloidosis--a diagnostic primer.
    Gertz MA; Kyle RA
    Mayo Clin Proc; 1989 Dec; 64(12):1505-19. PubMed ID: 2513459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longterm complete remission of AL-amyloid-related nephrotic syndrome.
    Fujigaki Y; Takahashi S; Yonemura K; Suzuki H; Togawa A; Fukasawa H; Goto T; Yamamoto T; Hishida A
    Clin Exp Nephrol; 2003 Sep; 7(3):250-3. PubMed ID: 14586724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.